myricanol has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dai, GH; Meng, GM; Ren, ZM; Tong, YL; Wang, K; Yang, F | 1 |
| Chai, K; Chen, X; Dai, G; Ren, Z; Tong, Y; Yang, F; Ying, X | 1 |
2 other study(ies) available for myricanol and Cancer of Lung
| Article | Year |
|---|---|
Growth-inhibiting and apoptosis-inducing activities of Myricanol from the bark of Myrica rubra in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Diarylheptanoids; Humans; Lung Neoplasms; Myrica; Plant Bark; Plant Extracts | 2014 |
Myricanol induces apoptotic cell death and anti-tumor activity in non-small cell lung carcinoma in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diarylheptanoids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Mice; Mice, Nude; Polyethylene Glycols; Survivin; Up-Regulation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |